Page last updated: 2024-11-06

triethylenemelamine and Carcinoma, Epidermoid

triethylenemelamine has been researched along with Carcinoma, Epidermoid in 4 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FEIND, CR1
HERTER, F1
MARKOWITZ, A1
JOHNSTON, ID1
Sugiura, K1
Comorosan, S1
Vieru, S1
Gaspar, A1
Sandru, D1

Other Studies

4 other studies available for triethylenemelamine and Carcinoma, Epidermoid

ArticleYear
IMPROVEMENTS IN ISOLATION HEAD PERFUSION.
    American journal of surgery, 1963, Volume: 106

    Topics: Carcinoma, Squamous Cell; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Child; Chordom

1963
THE TREATMENT OF MALIGNANT DISEASE BY REGIONAL CHEMOTHERAPY.
    The Ulster medical journal, 1963, Volume: 32

    Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Per

1963
Chemotherapy of induced skin tumors in mice.
    Gan, 1968, Volume: 59, Issue:5

    Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Benz(a)Anthracenes; Busulfan; Ca

1968
Nucleic acids and protein biosynthesis during alkylation with triethylenemelamine in kb-cells.
    Zeitschrift fur Krebsforschung, 1968, Volume: 71, Issue:2

    Topics: Absorption; Adenine; Alkylation; Arginine; Carbon Isotopes; Carcinoma, Squamous Cell; Culture Techni

1968